Barclays raises Estee Lauder stock price target on turnaround progress

Barclays raised Estée Lauder's price target to $75 from $72 while keeping an Equalweight rating, citing improving execution on its Beauty Reimagined turnaround. The company posted fiscal Q3 2026 organic growth of 1.6%, about 10 bps above consensus, and reported EPS of $0.91 versus $0.65 expected on revenue of $3.71 billion versus $3.69 billion expected. Despite the better results, the stock already trades at $79.30, above Barclays' new target.

Analysis

The market is treating EL like a self-help story, but the key question is not whether the turnaround is improving — it is whether the improvement is durable enough to justify a premium multiple. The evidence suggests a transition from “stabilization” to “re-acceleration,” but only if management can keep growth broad enough to avoid being dismissed as mix/price/margin timing. In consumer brands, once the easy base effects roll off, the stock usually stops trading on narrative and starts trading on repeatable sell-through, so the next 2-3 quarters matter more than the last one.

The second-order winner is likely the prestige channel ecosystem that can absorb share from weaker mass-tied beauty names and underinvested department-store brands. Bobbi Brown’s distribution pruning is strategically important because it should improve brand control, pricing power, and inventory discipline; that can create a cleaner wholesale read-through for peers with stronger DTC and selectivity, while pressuring lower-end distributors that relied on broad placement. The hidden risk is that a cleaner channel mix can temporarily flatter growth while masking weaker unit velocity — if that happens, replenishment will slow after the initial reset.

The main catalyst stack is the next two earnings prints and, more importantly, management’s ability to sustain 5%+ top-line trajectory without relying on gross margin expansion. If top-line growth stalls in the low-single digits, the market will likely de-rate the stock quickly because the current setup leaves limited room for multiple expansion. The longer-duration bull case only works if the company proves it can compound premium-brand share gains across geographies, not just deliver one-off operational repair.

The contrarian take is that the stock may already be priced for too much of the turnaround, especially with the shares above the revised target and sentiment improving. That creates a asymmetric setup for a pair trade: the upside from here is likely incremental, while any stumble in demand or wholesale read-through could compress the multiple sharply. In other words, the business can keep improving while the stock still underperforms if the market concludes the recovery is good, but not good enough for a premium.

Key Decisions for Investors

• Trim or avoid adding to EL on strength; use rallies to reduce exposure over the next 2-4 weeks unless management guidance starts implying sustained 5%+ organic growth.
• If wanting upside exposure, buy a limited-risk call spread in EL into the next earnings window; structure for a moderate re-rating, not a breakout, because valuation already discounts much of the turnaround.
• Pair trade: long EL / short a weaker prestige or department-store beauty proxy over 1-2 quarters if you believe channel rationalization will widen share gaps; otherwise consider the opposite if sell-through data softens after the reset.
• Set a hard stop on EL if organic growth reverts below 1% for a quarter, because that would undercut the premium-multiple thesis and likely trigger fast de-rating.
• Monitor inventory commentary and wholesale replenishment over the next 30-60 days; if retailer orders do not reaccelerate, fade the stock despite headline earnings beats.